Clinical and biological predictors of time to initiation of symptomatic therapy in early Parkinson’s disease
Objective: To determine clinical and biological variables that predict time to initiation of symptomatic therapy (TIST) in de novo Parkinson's disease (PD) patients. Background: There…Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
Objective: To evaluate baseline predictors and longitudinal impact of amantadine use in Parkinson's disease (PD). Background: There is preclinical data that amantadine has neuroprotective properties,…LSVT-BIG© case studies: A snapshot of observations
Objective: This case presentation will outline two clients treated with LSVT –BIG and share some observations of the technique. Background: It is estimated that seven…A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson’s disease
Objective: To investigate the potential of cognitive training to improve symptoms of freezing of gait in Parkinson's disease. Background: Freezing of gait (FOG) is a…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.